Clinical Focus

  • Hospice and Palliative Medicine
  • Supportive Oncology

Academic Appointments

Administrative Appointments

  • Medical Director, Oncology Palliative Care, Stanford Healthcare (2017 - Present)

Professional Education

  • Medical Education:Midwestern University (2008) AZ
  • Board Certification: Hospice and Palliative Medicine, American Board of Family Medicine (2012)
  • Board Certification: Family Medicine, American Board of Family Medicine (2011)
  • Board Certification, Palliative Medicine, American Board of Medical Specialties (2012)
  • Fellowship:Stanford University HPM Fellowship Program (2012) CA
  • Residency:Scottsdale Healthcare (2011) AZ


Graduate and Fellowship Programs


All Publications

  • Dronabinol for the Treatment of Paraneoplastic Night Sweats in Cancer Patients: A Report of Five Cases. Journal of palliative medicine Carr, C., Vertelney, H., Fronk, J., Trieu, S. 2019


    BACKGROUND: Night sweats significantly impact the quality of life for cancer patients and are often resistant to treatment. Cannabinoids have been shown to modulate cytokine activity and produce hypothermia in animal models, suggesting that they may be a promising candidate for palliation of night sweats in patients with oncologic disease.OBJECTIVE: Assess efficacy of the oral cannabinoid, dronabinol, for palliation of night sweats in cancer patients.DESIGN: A retrospective record search identified five cancer patients who had tried oral dronabinol for palliation of their night sweats between 2013 and 2016 and subjectively reported on its efficacy.SETTING/SUBJECTS: A convenience sample of five patients from the outpatient consultative palliative medicine program at Stanford Medical Center was chosen from a search of past records. Patients were included if they had a cancer diagnosis and complained of night sweats that subjectively interfered with their quality of life. All agreed to try oral dronabinol for palliation of their night sweats.MEASUREMENTS: Patients self-reported the effect of oral synthetic dronabinol on their night sweats.RESULTS: Treatment of five patients with advanced cancer with synthetic orally administered dronabinol resulted in the successful management of persistent symptomatic paraneoplastic night sweats.CONCLUSION: Dronabinol and/or medicinal cannabis are promising therapies for palliation of night sweats in cancer patients.

    View details for PubMedID 30759037

  • The Birds and Bees Do It, So Why Can't We Talk About It? Intimacy and Sexuality in Serious Illness and at the End of Life Shaw, H., Fronk, J., Hui, F., Lorenz, K., Schroeder, K., Kenemuth, R., Bober, S. ELSEVIER SCIENCE INC. 2017: 343
  • PALLIATIVE CARE AND ANTI-CANCER CARE INTEGRATION: DESCRIPTION OF THREE MODELS OF CARE DELIVERY AT A TERTIARY MEDICAL CENTER Ramchandran, K. J., Fronk, J., Trieu, S., Wakelee, H. A., Das, M., Neal, J. W., Harman, S., Dwyer, P., Bosch, J., Shaw, H., Safari, S., Oden, R., Morrison, T., Blayney, D. LIPPINCOTT WILLIAMS & WILKINS. 2013: S1324